This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (5) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Fineberg, N. A. Articles by Sivakumaran, T. Search for Related Content PubMed PubMed Citation Articles by Fineberg, N. A. Articles by Sivakumaran, T. Pubmed/NCBI databases Medline Plus Health Information Obsessive-Compulsive Disorder Social Bookmarking                         What's this?

A review of antipsychotics in the treatment of obsessive compulsive disorder

Department of Psychiatry, Queen Elizabeth II Hospital, Welwyn Garden City, Hertfordshire, AL7 4HQ, UK and Department of Psychology, University of Hertfordshire, College Lane, Hatfield, Hertfordshire, AL10 9AB, UK, naomi.fineberg{at}btinternet.com

Tim M. Gale

Department of Psychiatry, Queen Elizabeth II Hospital, Welwyn Garden City, Hertfordshire, AL7 4HQ, UK and Department of Psychology, University of Hertfordshire, College Lane, Hatfield, Hertfordshire, AL10 9AB, UK

Thanusha Sivakumaran

Department of Psychiatry, Queen Elizabeth II Hospital, Welwyn Garden City, Hertfordshire, AL7 4HQ, UK

References

• Ackerman D L, Greenland S (2002) Multivariate meta-analysis of controlled drug studies for obsessive compulsive disorder . J Clin Psychopharmacol 22: 309-317 [CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Altschuler M (1962) Massive doses of trifluoperazine in the treatment of compulsive rituals . Am J Psychiat 119: 367-368 [Abstract/Free Full Text]
• Atmaca M, Kuloglu M, Tezcan E, Gecici O (2002) Quetiapine augmentation in patients with treatment-resistant obsessive compulsive disorder. A single blind, placebo-controlled study . Int Clin Psychopharmacol 17: 115-119 [CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Barr L C, Goodman W K, Anand A, McDougle C J, Price L H (1997) Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder . Am J Psychiat 154: 1293-1295 [Abstract]
• Barr L C, Goodman W K, McDougle C J, Delgado P L, Heninger G R, Charney D S, Price L H (1994) Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors . Arch Gen Psychiat 51: 309-317 [Abstract/Free Full Text]
• Bejerot S, Bodlund O (1998) Response to high doses of citalopram in treatment-resistant obsessive compulsive disorder . Acta Psychopharmacol Scandinavia 98: 423-424
• Blier P, Bergeron R (1996) Sequential administration of augmentation strategies in treatment resistant obsessive compulsive disorder: preliminary findings . Int Clin Psychopharmacol 11: 37-44 [Web of Science][Medline] [Order article via Infotrieve]
• Bogan A M, Koran L M, Chuong H V, Vapnik T, Bystritsky A (2005) Quetiapine augmentation in obsessive compulsive disorder resistant to serotonin reuptake inhibitors: an open label study . J Clin Psychiat 66: 73-79 [Web of Science][Medline] [Order article via Infotrieve]
• Bogetto F, Bellino S, Vaschetto P, Ziero S (2000) Olanzapine augmentation of fluvoxamine-refractory obsessive compulsive disorder (OCD): a twelve-week open trial . Psychiat Res 95: 91-98 [CrossRef]
• Buchsbaum M S, Hollander E, Pallanti S, Baldini-Rossi N, Platholi J, Bloom R, Sood E (2002) Risperidone in Refractory OCD: Positron Emission Tomography Imaging . 42nd NCDEU Meeting, Boca Raton
• Bymaster F P, Katner J S, Nelson D L, Hemrick-Luecke S K, Threlkeld P G, Heilingstein J H, Morin S M, Gehlert D R, Perry K W (2002) Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder . Neuropsychopharmacology 27(5): 699-711 [CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Byerly M J, Goodman W K, Christenen R (1996) High doses of sertraline for treatment-resistant obsessive compulsive disorder . Am J Psychiat 153: 1232-1233 [Web of Science][Medline] [Order article via Infotrieve]
• Bystritsky A, Ackerman D L, Rosen R, Vapnik T, Gorbis E, Maidment K M, Saxena S (2004) Augmentation of SSRI response in refractory obsessive-compulsive disorder using adjunctive olanzapine: a placebo-controlled trial . J Clin Psychiat 65: 565-568 [Web of Science][Medline] [Order article via Infotrieve]
• Carey P D, Vythilingum B, Seedat S, Muller J E, van Ameringen M, Stein D J (2005) Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study : BMC Psychiat 5(1): 5 [CrossRef]
• Connor K M, Payne V M, Gadde K M, Zhang WDavidson J R (2005) The use of aripiprazole in obsessive compulsive disorder: preliminary observations in 8 patients . J Clin Psychiat 66(1): 49-51 [Web of Science][Medline] [Order article via Infotrieve]
• Crocq M A, Leclercq P, Guillon M S, Bailey P E (2002) Open-label olanzapine in obsessive compulsive disorder refractory to antidepressant treatment . Eur Psychiat 17: 296-297 [CrossRef]
• D’Amico G, Cedro C, Muscatello M R, Pandolfo G, Di Rosa A E, Zoccali R, La Torre D, D’Amigo C, Spina E (2003) Olanzapine augmentation of paroxetine-refractory obsessive-compulsive disorder . Progress in Neuro-psychopharmacology and Biological Psychiat 27: 619-623 [CrossRef]
• Dannon P N, Sasson Y, Hirschmann S, Iancu I, Grunhaus L J, Zohar J (2000) Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo-controlled trial . Eur Neuropsychopharmacol 10: 165-169 [Web of Science][Medline] [Order article via Infotrieve]
• Denys D, de Geus F, van Megen H J G M, Westenberg H G M (2004a) A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive compulsive disorder refractory to serotonin reuptake inhibitors . J Clin Psych 65: 1040-1048 [Web of Science][Medline] [Order article via Infotrieve]
• Denys D, Klompmakers A A, Westenberg H G (2004c) Synergistic dopamine increase in the rat prefrontal cortex with the combination of quetiapine and fluvoxamine . Psychopharmacology (Berl) 176(2): 195-203 [CrossRef][Medline] [Order article via Infotrieve]
• Denys D, van der Wee N, Janssen J, De Geus F, Westenberg H G (2004b) Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder . Biol Psychiat 55: 1041-1045 [CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Denys D, van Megen H, Westenberg H (2002) Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment refractory obsessive compulsive disorder: an open label study . J Clin Psychiat 63: 700-703 [Web of Science][Medline] [Order article via Infotrieve]
• Erzegovesi S, Guglielmo E, Siliprandi F, Bellodi L (2005) Low-dose risperidone augmentation of fluvoxamine treatment for obsessive compulsive disorder: a double-blind placebo-controlled study . Eur Neuropsychopharmacol 15(1): 69-74 [CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Fallon B A, Liebowitz M R, Campeas R, Schneier F R, Marshall R, Davies S, Goetz D, Klein D F (1998) Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study . Arch Gen Psychiat 55: 918-924 [Abstract/Free Full Text]
• Fineberg N A, Sivakumaran T, Roberts A, Gale T (2005) Adding quetiapine to SRI in treatment-resistant obsessive compulsive disorder: a randomised controlled treatment study . Int Clin Psychopharmacol 20: 223-226 [CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Francobandiera G (2001) Olanzapine augmentation of serotonin uptake inhibitors in obsessive compulsive disorder: an open study . Can J Psychiat 46: 356-358 [Web of Science][Medline] [Order article via Infotrieve]
• Geller D A, Biederman J, Evelyn Stewart S, Mullin B, Martin A, Spencer T, Faraone S V (2003) Which SSRI? A meta-analysis of pharmacotherapy trials in paediatric obsessive compulsive disorder . Am J Psychiat 160: 1919-1928 [Abstract/Free Full Text]
• Grady T A, Pigott T A, L’Heureux F, Hill J L, Berntein S E, Murphy D L (1993) Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder . Am J Psychiat 150: 819-821 [Abstract/Free Full Text]
• Hollander E, Rossi N B, Sood E, Pallanti S (2003a) Risperidone augmentation in treatment-resistant obsessive compulsive disorder: a double-blind, placebo controlled study . Int J Neuropsychopharmacol 6: 397-401 [CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Hollander E, Kaplan A, Stahl S M (2003b) A double-blind placebo-controlled trial of clonazepam in obsessive-compulsive disorder . World J Biological Psychiat 4: 30-34
• Hussain M Z, Ahad A (1970) Treatment of obsessive compulsive neurosis . Can Med Assoc J 103: 648 [Medline] [Order article via Infotrieve]
• Koran L M, Ringold A L, Elliott M A (2000) Olanzapine augmentation for treatment-resistant obsessive compulsive disorder . J Clin Psychiat 61: 514-517 [Web of Science][Medline] [Order article via Infotrieve]
• Maina G, Albert U, Ziero S, Bogetto F (2003) Antipsychotic augmentation for treatment-resistant obsessive compulsive disorder: What if antipsychotic is discontinued? Int Clin Psychopharmacol 18: 23-28 [CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• March J S, Frances A, Kahn D A, Carpenter D (1997) The Expert Consensus Guideline Series: treatment of obsessive-compulsive disorder . J Clin Psychiat 58 (suppl.): 1-72
• Marek G J, Carpenter L L, McDougle C J, Price L H (2003) Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders . Neuropsychopharmacol 28: 402-412 [CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Mataix-Cols D, Rauch S, Manzo P A, Jenike M A, Baer L (1999) Use of factor-analysed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive compulsive disorder . Am J Psychiat 156: 1409-1416 [Abstract/Free Full Text]
• McDougle C J, Barr L C, Goodman W K, Pelton G H, Aronson S C, Anand A, Price L H (1995b) Lack of efficacy of clozapine monotherapy in refractory obsessive-compulsive disorder . Am J Psychiat 152: 423-429
• McDougle C J, Epperson C N, Pelton G H, Wasylink S, Price L H (2000) A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder . Arch Gen Psychiat 57: 794-801 [Abstract/Free Full Text]
• McDougle C J, Fleischmann R L, Epperson C N, Wayslink S, Leckmann J F, Price L H (1995a) Risperidone addition in fluvoxamine refractory obsessive compulsive disorder: three cases . J Clin Psychiat 56: 526-528 [Web of Science][Medline] [Order article via Infotrieve]
• McDougle C J, Goodman W K, Leckman J F, Holzer J C, Barr L C, McCance-Katz E (1993) Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive compulsive disorder . Am J Psychiat 150: 647-649 [Abstract/Free Full Text]
• McDougle C J, Goodman W K, Leckman J F, Lee N C, Heninger G R, Price L H (1994) Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder: a double-blind placebo-controlled study in patients with and without tics . Arch Gen Psychiat 51: 302-308 [Abstract/Free Full Text]
• McDougle C J, Goodman W K, Price L H, Delgado P L, Krystal J H, Charney D S, Heninger G R (1990) Neuroleptic addition in fluvoxamine-refractory obsessive compulsive disorder . Am J Psychiat 147: 652-654 [Abstract/Free Full Text]
• McDougle C J, Price L H, Goodman W K, Charney D S, Heninger G R (1991) A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive compulsive disorder: lack of efficacy . J Clin Psychopharmacol 11: 175-184 [Web of Science][Medline] [Order article via Infotrieve]
• McDougle C J, Walsh K H (2001) Treatment for refractory OCD. In: Fineberg N A, Marazitti D, Stein D (eds), Obsessive Compulsive Disorder: A Practical Guide. Martin Dunitz, London
• Metin O, Yaziki K, Tot S, Yazici A E (2003) Amisulpride augmentation in treatment-resistant obsessive compulsive disorder: an open trial . Hum Psychopharmacol 18: 463-467 [CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Mohr N, Vythilingum B, Emsley R A, Stein D J (2002) Quetiapine augmentation of serotonin reuptake inhibitors in obsessive compulsive disorder . Int Clin Psychopharmacol 17: 37-40 [CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Mundo E, Bareggi S R, Pirola R, Bellodi L (1999) Effect of acute intravenous clomipramine and antiobsessional response to proserotonergic drugs: Is gender a predictive variable? Biol Psychiat 45: 290-294 [CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Mundo E, Guglielmo E, Bellodi L (1998) Effect of adjuvant pindolol on the antiobsessional response to fluvoxamine; a double-blind, placebo-controlled study . Int Clin Psychopharmacol 13: 219-224 [Web of Science][Medline] [Order article via Infotrieve]
• O’Regan J B (1970) Treatment of obsessive-compulsive neurosis . Can Med Assoc J 103: 650-651 [Medline] [Order article via Infotrieve]
• Pallanti S, Hollander E, Bienstock C, Koran L, Leckman J, Marazziti D, Pato M, Stein D, Zohar and the International Treatment-Refractory OCD Consortium (2002a) Treatment non-response in OCD: methodological issues and operational definitions . Int J Neuropsychopharmacol 5: 181-191 [CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Pallanti S, Quercioli L, Bruscoli M (2004) Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study . J Clin Psychiat 65(10): 1394-1399 [Web of Science][Medline] [Order article via Infotrieve]
• Pallanti S, Quercioli L, Koran L M (2002b) Citalopram infusions in resistant obsessive compulsive disorder: an open trial . J Clin Psychiat 63: 796-801 [Web of Science][Medline] [Order article via Infotrieve]
• Pallanti S, Quercioli L, Paiva R S, Koran L M (1999) Citalopram for treatment-resistant obsessive-compulsive disorder . Eur Psychiat 14: 101-106 [CrossRef]
• Pfanner C, Marazziti D, Dell’Osso L, Presta S, Gemignani A, Milanfranchi A, Cassano G B (2000) Risperidone augmentation in refractory obsessive compulsive disorder: an open-label study . Int Clin Psychopharmacol 15: 297-301 [Web of Science][Medline] [Order article via Infotrieve]
• Pigott T A, L’Heureux F, Hill J L, Bihari K, Bernstein S E, Murphy D L (1992a) A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive compulsive disorder . J Clin Psychopharmacol 12: 11-18 [Web of Science][Medline] [Order article via Infotrieve]
• Pigott T A, L’Heureux F, Rubinstein C F, Hill J L, Murphy D L (1992b) A controlled trial of clonazepam augmentation in OCD patients treated with clomipramine or fluoxetine . New Research Abstracts NR 144 presented at the 145th Annual Meeting of the American Psychiatric Association, Washington, DC, USA
• Pigott T A, Pato M T, L’Heureux F, Hill J L, Grover G N, Bernstein S E, Murphy D L (1991) A controlled comparison of adjuvant lithium carbonate or thyroid hormone in clomipramine-treated patients with obsessive compulsive disorder . J Clin Psychopharmacol 11: 242-248 [Web of Science][Medline] [Order article via Infotrieve]
• Poyurovsky M, Koran L (2005) Obsessive compulsive disorder (OCD) with schizotypy vs. schizophrenia with OCD: diagnostic dilemmas and therapeutic implications . J Psychiatr Res 39(4): 399-408 [CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Rivers-Bulkeley N, Hollender M H (1982) Successful treatment of obsessive-compulsive disorder with loxapine . Am J Psychiat 139: 1345-1346 [Abstract/Free Full Text]
• Sareen J, Kirshner A, Lander M, Kjeniested K D, Eleff M K, Reiss J P (2004) Do antipsychotics ameliorate or exacerbate obsessive compulsive disorder? A systematic review . J Affective Disorders 82: 167-174 [CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Saxena S, Brody A L, Ho M L, Zohrabi N, Maidment K M, Baxter L (2003) Differential brain metabolic predictors of response to paroxetine in obsessive compulsive disorder versus major depression . Am J Psychiat 160: 522-532 [Abstract/Free Full Text]
• Saxena S, Wang D, Bystritsky A, Baxter Jr L R (1996) Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder . J Clin Psychiat 57: 303-306 [Web of Science][Medline] [Order article via Infotrieve]
• Sevincok L, Topuz A (2003) Lack of efficacy of low dose quetiapine addition in refractory obsessive compulsive disorder . J Clin Psychopharmacol 23: 448-450 [Web of Science][Medline] [Order article via Infotrieve]
• Shapira N A, Ward H E, Mandoki M, Murphy T K, Yang M C, Blier P, Goodman W K (2004) A double-blind placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive compulsive disorder . Biol Psychiat 55: 553-563 [CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Stein D J, Bouwer C, Hawkridge S, Emsley R A (1997) Risperidone augmentation of serotonin reuptake inhibitors in obsessive compulsive and related disorders . J Clin Psychiat 58: 119-122 [Web of Science][Medline] [Order article via Infotrieve]
• Stein D, Montgomery S A, Kasper S, Tanghoj P (2001) Predictors of response to pharmacotherapy with citalopram in obsessive compulsive disorder . Int Clin Psychopharmacol 16: 357-361 [CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Szegedi A, Wetzel H, Leal M, Hartter S, Hiemke C (1996) Combination treatment with clomipramine and fluvoxamine: drug monitoring, safety and tolerability data . J Clin Psychiat 57: 257-264 [Web of Science][Medline] [Order article via Infotrieve]
• Trethowan W H, Scott P A (1955) Chlorpromazine in obsessive-compulsive and allied disorders . Lancet 268: 781-785 [CrossRef][Medline] [Order article via Infotrieve]
• Weiss E L, Potenza M N, McDougle C J, Epperson C N (1999) Olanzapine addition in obsessive compulsive disorder refractory to selective serotonin reuptake inhibitors; an open-label case series . J Clin Psychiat 60: 524-527 [Web of Science][Medline] [Order article via Infotrieve]

This version was published on January 1, 2006

Journal of Psychopharmacology, Vol. 20, No. 1, 97-103 (2006)
DOI: 10.1177/0269881105056640


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				K. Mukhopadhaya, R. Krishnaiah, T. Taye, A. Nigam, A. Bailey, T. Sivakumaran, and N. Fineberg Obsessive-compulsive disorder in UK clozapine-treated schizophrenia and schizoaffective disorder: a cause for clinical concern J Psychopharmacol, January 1, 2009; 23(1): 6 - 13. [Abstract] [PDF]

				L. M. Koran M.D. Obsessive-Compulsive Disorder: An Update for the Clinician Focus, January 1, 2007; 5(3): 299 - 313. [Full Text] [PDF]

				Bibliography for Obsessive-Compulsive Disorder Focus, January 1, 2007; 5(3): 328 - 329. [Full Text] [PDF]

This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (5) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Fineberg, N. A. Articles by Sivakumaran, T. Search for Related Content PubMed PubMed Citation Articles by Fineberg, N. A. Articles by Sivakumaran, T. Pubmed/NCBI databases Medline Plus Health Information Obsessive-Compulsive Disorder Social Bookmarking                         What's this?